Find a Provider

Rita-Salani Photo

Specialty:: Obstetrics and Gynecology
Department Affiliation:: Obstetrics and Gynecology
Hospital Affiliation:: Ronald Reagan UCLA Medical Center
UCLA Santa Monica Medical Center
State License:: C168631
Health Plans:: Accepted Plans

Medical Board Certifications: Obstetrics and Gynecology, American Board of Obstetrics and Gynecology, 2010
Certification 2: Gynecologic Oncology, American Board of Obstetrics and Gynecology, 2012
Fellowship: Gynecologic Oncology, Johns Hopkins University School of Medicine-GME, 2005-2008
Residency: Obstetrics & Gynecology, Emory University School of Medicine, 2001-2005
Degree: Northeast Ohio Medical University, MD, 2001

Interests

Cervical Cancer
Cervical Cancer: Introduction
Cervical cancer develops from abnormal cells on the surface of the cervix that spread deeper or spread to other tissues or organs.
Learn more >
Clinical Trials
Gynecologic Cancer Surgery
Gynecologic Oncology
Gynecological Cancers
Detailed information on the most common types of gynecological cancers, including symptoms, risk factors, diagnosis, and treatment. There are several different types of gynecological cancer require the care of a health care provider. A brief overview of Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Uterine Cancer, Vaginal Cancer, Vulvar Cancer is provided.
Learn more >

Publications

Barnes DR, Rookus MA, McGuffog L…Salani R…Antoniou AC. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA 1 and BRCA 2 pathogenic variants. Genet Med 2020, accepted for publication. PMID 32665703
Harkenrider MM, Markham MJ, Dizon DS, Jhingran A, Salani R, Serour RK, Lynn J, Kohn EC. Moving forward in cervical cancer-enhancing susceptibility to DNA repair inhibition and damage: NCI Clinical Trials Planning Meeting Report. J Natl Cancer Inst 2020; accepted for publication. PMID 32219419
Teoh D, Musa F, Salani R, Huh W, Jimenez E. Diagnosis and management of adenocarcinoma in situ: A Society of Gynecologic Oncology evidence-based review and recommendations. Obstet Gynecol 2020;135(4):869-78. PMID 32168211
Chase D, Huang HQ, Monk BJ…Salani R…Tewari KS. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study. Int J Gynecol Cancer 2020;30(5):596-601. PMID 32114513
Hutchcraft ML, Smith B, McLaughlin EM, Hade EM, Backes FJ, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ, Salani R. Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer. Gynecol Oncol 2019; 153(2):255-8. PMID 30718123
Rose PG, Java JJ, Salani R…Copeland LJ. Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma. Obstet Gynecol 2019;133;(2):245-254. PMID 30633128
Randall ME, Filiaci V, McMeekin DS…Salani R…Miller DS. Phase III trial of adjuvant pelvic radiation therapy versus vaginal cuff brachytherapy plus paclitaxel/carboplatin chemotherapy in high-intermediate and high risk, early stage endometrial cancer. J Clin Oncol 2019;37(21):1810-18. PMID 30995174
von Gruenigen VE, Huang HQ, Cella D, Zevon M, LaChance JA, Waker JL, Salani R, Modesitt SC, Morris RT, Bradley WH, Boente MP, Wenzel L. Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol 2018;150(1):119-26. PMID 29778506
Salani R, Khanna N, Frimer M, Bristow RE, Chen LM. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecol Oncol 2017;146(1):3-10. PMID 28372871
Thaker PH*, Salani R*, Brady WE, Lankes HA, Cohn DE, Mutch DG, Mannel RS, Bell-McGuinn KM, DiSilvestro PA, Jelovac D, Carter JS, Duan W, Resnick KE, Dizon DS, Aghajanian C, Fracasso PM. A phase I trial of paclitaxel, cisplatin and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology Study (NCT#01281852). Ann Oncol 2016;28(3):505-511. PMID 27998970 *Both authors contributed equally for first authorship.

Awards: Best Doctors in America, 2012-2020

GOG Scholar Investigator Award, 2019

APGO Excellence in Teaching Award, 2015

Ritu Salani, MD click here to update your profile

Back to search

Find a Provider

Find a Provider

Cervical Cancer: Introduction

Gynecological Cancers